106 related articles for article (PubMed ID: 66687)
1. Hormonal status in prostatic disease.
Frick J; Bartsch G
Prog Clin Biol Res; 1976; 6():143-58. PubMed ID: 66687
[No Abstract] [Full Text] [Related]
2. [Value of testosterone, FSH and LH on plasma in patients with prostatic adenoma and carcinoma before and after different hormonal treatments].
Garcia de la Peña E; Ramos F; Horcajada C; Cifuentes Delatte L; Vivanco F
Rev Clin Esp; 1978 Jan; 148(1):19-23. PubMed ID: 76325
[No Abstract] [Full Text] [Related]
3. [Hormone determinations in andrology].
Frick J
Andrologia; 1980; 12(3):211-8. PubMed ID: 6778255
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia.
Cochran RC; Ewing LL; Niswender GD
Invest Urol; 1981 Nov; 19(3):142-7. PubMed ID: 6170603
[TBL] [Abstract][Full Text] [Related]
5. Control of prostate growth.
Coffey DS; Isaacs JT
Urology; 1981 Mar; 17(Suppl 3):17-24. PubMed ID: 6163242
[No Abstract] [Full Text] [Related]
6. Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer.
Hsing AW; Comstock GW
Cancer Epidemiol Biomarkers Prev; 1993; 2(1):27-32. PubMed ID: 8420607
[TBL] [Abstract][Full Text] [Related]
7. [The influence of spironolactone on the concentration of gonadotrophins and gonadal hormones in prostatic hypertrophy (author's transl)].
Zgliczynski S; Baranowska B; Szymanowski J
J Urol (Paris); 1981; 87(9):635-8. PubMed ID: 6174646
[TBL] [Abstract][Full Text] [Related]
8. [Hormonal disturbances in men with a prostatic adenoma (author's transl)].
Baranowska B; Zgliczynski S; Szymanowski J
J Urol (Paris); 1980; 86(7):551-8. PubMed ID: 6161196
[TBL] [Abstract][Full Text] [Related]
9. [Hormonal environment and antiandrogenic treatment in benign prostatic hypertrophy].
Katayama T; Umeda K; Kazama T
Hinyokika Kiyo; 1986 Nov; 32(11):1584-9. PubMed ID: 2435122
[TBL] [Abstract][Full Text] [Related]
10. [Hormonal changes in carcinoma of the prostate].
Rodrigues-Netto Júnior N; Da Silva RP; Hernández AJ
Rev Paul Med; 1979; 94(1-2):24-6. PubMed ID: 120973
[No Abstract] [Full Text] [Related]
11. Testosterone levels in benign prostatic hypertrophy and prostate cancer.
Mearini L; Costantini E; Zucchi A; Mearini E; Bini V; Cottini E; Porena M
Urol Int; 2008; 80(2):134-40. PubMed ID: 18362481
[TBL] [Abstract][Full Text] [Related]
12. A study of the endocrine manifestations of hepatic cirrhosis.
Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
[TBL] [Abstract][Full Text] [Related]
13. [Treatment with D-Trp-6-LHRH. Plasma levels and gonadotropic response].
Lahlou N; Duchier J; Feinstein MC; Mauvernay RY; Roger M; Schally AV
Pathol Biol (Paris); 1984 Oct; 32(8):906-8. PubMed ID: 6209605
[No Abstract] [Full Text] [Related]
14. [Hormonal status of patients with uterine cancer during surgical treatment].
Musina RKh; Kiseleva NS; Modnikov OP
Vopr Onkol; 1987; 33(8):99-102. PubMed ID: 2820150
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of benign prostatic hyperplasia with the preparation Gentos].
Pecherskiĭ AV; Aleksandrov VP; Mazurov VI; Kniaz'kin IV; Zeziulin PN; Nikolaeva EV
Urologiia; 2000; (5):16-7. PubMed ID: 11392216
[No Abstract] [Full Text] [Related]
16. Influence of radical prostatectomy on serum hormone levels.
Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
[TBL] [Abstract][Full Text] [Related]
17. Plasma steroid and protein hormone concentrations in patients with benign prostatic hypertrophy and in normal men.
Ortega E; Ruiz E; Mendoza MC; Martin-Andres A; Osorio C
Experientia; 1979 Jun; 35(6):844-5. PubMed ID: 89045
[TBL] [Abstract][Full Text] [Related]
18. [Interdependence between hormonal disorders, stage of development and degree of malignancy of prostatic cancer. 1].
Szymanowski J; Baranowska B; Niewiadomska A; Wysocki M; Kobuszewska-Faryna M; Zgliczynski S
J Urol (Paris); 1983; 89(8):597-600. PubMed ID: 6677708
[TBL] [Abstract][Full Text] [Related]
19. [Changes of serum testosterone-estradiol-binding globulin, follicular stimulating hormone, luteinizing hormone, estradiol, progesterone, and testosterone levels in women associated with aging].
Kamatsuki S
Igaku Kenkyu; 1982 Nov; 52(5):243-55. PubMed ID: 6821181
[No Abstract] [Full Text] [Related]
20. Hormones and the pathophysiology of fibrocystic mastopathy: elevated luteinizing hormone levels.
Golinger RC; Krebs J; Fisher ER; Danowski TS
Surgery; 1978 Aug; 84(2):212-5. PubMed ID: 684613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]